Latest filing published 01 Mar 2017 for CoLucid Pharmaceuticals, Inc., €159k. Read the official filing
Raymond Skwierczynski appears in our data through filings on CoLucid Pharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 10 June 2016 to 1 March 2017, the count stands at 10 filings.
Sales make up the whole of the open-market record (9 sales, €31k).
The newest entry dates from 1 March 2017: a transaction of €159k, in CoLucid Pharmaceuticals, Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations